Alpha DNA Investment Management’s Enova International ENVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,041
Closed -$483K 65
2024
Q4
$483K Sell
5,041
-576
-10% -$54.9K 0.18% 112
2024
Q3
$471K Buy
+5,617
New +$435K 0.18% 130
2022
Q3
Sell
-32,464
Closed -$935K 167
2022
Q2
$935K Buy
32,464
+716
+2% +$23.7K 0.8% 83
2022
Q1
$1.2M Buy
+31,748
New +$1.28M 0.85% 66

Other funds holding ENVA

Alpha DNA Investment Management's ENVA Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Enova International (ENVA) in Q1 2025, closing a stake of 5,041 shares — an estimated $483K sold.

Alpha DNA Investment Management first reported a position in ENVA in Q1 2022 and held it in 4 quarters. The position peaked at $1.2M in Q1 2022. 316 funds tracked by Wall St. Rank hold ENVA as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Enova International position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,041 Enova International shares in Q1 2025, an estimated $483K.
  • Alpha DNA Investment Management first reported a position in Enova International in Q1 2022 and held it in 4 quarters.
  • Alpha DNA Investment Management's Enova International position peaked at $1.2M in Q1 2022.
  • 316 funds tracked by Wall St. Rank held Enova International as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.